Lipid Transfer Proteins and PI4KIIα Initiate Nuclear p53-Phosphoinositide Signaling

Area of Science:

• Cellular signaling pathways
• Molecular mechanisms of DNA damage response
• Cancer biology and therapeutics

Background:

• Phosphoinositide (PIP) messengers regulate cellular processes, including DNA damage response, primarily through membrane-associated phosphatidylinositol (PI) 3-kinase (PI3K)/Akt pathways.
• A distinct nuclear PI3K/Akt pathway exists, involving p53 tumor suppressor protein and nuclear PIPs, but its upstream regulation remains poorly understood.
• PI transfer proteins (PITPs) are known to transport PI between membranes, facilitating PIP synthesis.

Purpose of the Study:

• To identify the upstream regulators of nuclear PIP synthesis and signaling in the context of p53 activation upon genotoxic stress.
• To elucidate the roles of PITPs and PI 4-kinases in the formation of p53-PIP complexes and subsequent nuclear Akt activation.
• To explore the therapeutic potential of targeting these newly identified nuclear signaling components.

Main Methods:

• Investigated protein-protein interactions between p53, PITPs, and PI 4-kinases in nuclear fractions.
• Utilized biochemical assays to assess PI transfer activity and catalytic activity of PI 4-kinases in p53-PIP complex formation.
• Analyzed the functional consequences of PITP and PI4KIIα modulation on p53 stability, nuclear Akt activation, and cellular stress resistance.

Main Results:

• Class I PITPs (PITPα/β) were identified as key suppliers of PI for nuclear p53-PIP complex generation.
• PI 4-kinase PI4KIIα was found to bind p53 and PITPs, catalyzing the formation of p53-PI4P, a precursor to p53-PIP_n complexes.
• The collaborative action of PITPα/β and PI4KIIα initiates p53-PIP signaling, regulating p53 stability, nuclear Akt activation, and genotoxic stress resistance.

Conclusions:

• PITPα/β and PI4KIIα act as critical upstream regulators of nuclear p53-phosphoinositide signaling.
• This pathway, occurring in membrane-free nuclear regions, is essential for cellular resistance to genotoxic stress.
• PITPα/β and PI4KIIα represent promising novel therapeutic targets for cancer treatment.